These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20697377)

  • 21. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.
    Larter CZ; Yeh MM; Williams J; Bell-Anderson KS; Farrell GC
    J Hepatol; 2008 Sep; 49(3):407-16. PubMed ID: 18534710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A methionine-choline-deficient diet induces nonalcoholic steatohepatitis and alters the lipidome, metabolome, and gut microbiome profile in the C57BL/6J mouse.
    Gautam J; Aggarwal H; Kumari D; Gupta SK; Kumar Y; Dikshit M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2024 Dec; 1869(8):159545. PubMed ID: 39089643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
    Koppe SW; Sahai A; Malladi P; Whitington PF; Green RM
    J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice.
    Itagaki H; Shimizu K; Morikawa S; Ogawa K; Ezaki T
    Int J Clin Exp Pathol; 2013; 6(12):2683-96. PubMed ID: 24294355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.
    Min AK; Kim MK; Kim HS; Seo HY; Lee KU; Kim JG; Park KG; Lee IK
    Life Sci; 2012 Jan; 90(5-6):200-5. PubMed ID: 22154902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory Effects of Sodium Alginate on Hepatic Steatosis in Mice Induced by a Methionine- and Choline-deficient Diet.
    Kawauchi S; Horibe S; Sasaki N; Tanahashi T; Mizuno S; Hamaguchi T; Rikitake Y
    Mar Drugs; 2019 Feb; 17(2):. PubMed ID: 30744124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis.
    Jung YA; Choi YK; Jung GS; Seo HY; Kim HS; Jang BK; Kim JG; Lee IK; Kim MK; Park KG
    Diabetes Res Clin Pract; 2014 Jul; 105(1):47-57. PubMed ID: 24842243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet.
    Nagasawa T; Inada Y; Nakano S; Tamura T; Takahashi T; Maruyama K; Yamazaki Y; Kuroda J; Shibata N
    Eur J Pharmacol; 2006 Apr; 536(1-2):182-91. PubMed ID: 16574099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visfatin exacerbates hepatic inflammation and fibrosis in a methionine-choline-deficient diet mouse model.
    Heo YJ; Choi SE; Lee N; Jeon JY; Han SJ; Kim DJ; Kang Y; Lee KW; Kim HJ
    J Gastroenterol Hepatol; 2021 Sep; 36(9):2592-2600. PubMed ID: 33600604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis.
    Pickens MK; Yan JS; Ng RK; Ogata H; Grenert JP; Beysen C; Turner SM; Maher JJ
    J Lipid Res; 2009 Oct; 50(10):2072-82. PubMed ID: 19295183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
    Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice.
    Leclercq IA; Farrell GC; Sempoux C; dela Peña A; Horsmans Y
    J Hepatol; 2004 Dec; 41(6):926-34. PubMed ID: 15582125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid metabolism, oxidative stress and cell death are regulated by PKC delta in a dietary model of nonalcoholic steatohepatitis.
    Greene MW; Burrington CM; Lynch DT; Davenport SK; Johnson AK; Horsman MJ; Chowdhry S; Zhang J; Sparks JD; Tirrell PC
    PLoS One; 2014; 9(1):e85848. PubMed ID: 24454937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stress signaling in the methionine-choline-deficient model of murine fatty liver disease.
    Soon RK; Yan JS; Grenert JP; Maher JJ
    Gastroenterology; 2010 Nov; 139(5):1730-9, 1739.e1. PubMed ID: 20682321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis.
    Wu W; Liu X; Peng X; Xue R; Ji L; Shen X; Chen S; Gu J; Zhang S
    Biochem Biophys Res Commun; 2014 May; 448(1):50-5. PubMed ID: 24747563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice.
    Zhang J; Zhang H; Deng X; Zhang N; Liu B; Xin S; Li G; Xu K
    Life Sci; 2018 Jan; 192():46-54. PubMed ID: 29158052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thioredoxin-binding protein-2 deficiency enhances methionine-choline deficient diet-induced hepatic steatosis but inhibits steatohepatitis in mice.
    Ahsan MK; Okuyama H; Hoshino Y; Oka S; Masutani H; Yodoi J; Nakamura H
    Antioxid Redox Signal; 2009 Oct; 11(10):2573-84. PubMed ID: 19764881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic vagus nerve regulates Kupffer cell activation via α7 nicotinic acetylcholine receptor in nonalcoholic steatohepatitis.
    Nishio T; Taura K; Iwaisako K; Koyama Y; Tanabe K; Yamamoto G; Okuda Y; Ikeno Y; Yoshino K; Kasai Y; Okuno M; Seo S; Sakurai T; Asagiri M; Hatano E; Uemoto S
    J Gastroenterol; 2017 Aug; 52(8):965-976. PubMed ID: 28044208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine-choline deficient diet by CCAAT/enhancer-binding protein homologous protein deficiency.
    Toriguchi K; Hatano E; Tanabe K; Takemoto K; Nakamura K; Koyama Y; Seo S; Taura K; Uemoto S
    J Gastroenterol Hepatol; 2014 May; 29(5):1109-18. PubMed ID: 24329600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.